RAJAT SOOD: Open Payments
NPI 1710441423 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 15 payments from 8 companies in 2025. Trend: 2023 $237 · 2024 $244 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| GENZYME CORPORATION | 3 | $51 |
| Optinose US, Inc. | 3 | $51 |
| Smith+Nephew, Inc. | 1 | $38 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Integra LifeSciences Corporation | 1 | $22 |
| Amgen Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: DUPIXENT, Xhance, NUCALA, ACCLARENT AERA, LIBTAYO, TAVNEOS, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
